M&C Life Science Co., Ltd. (XKON:A225860) announced a private placement of 5th series unregistered unguaranteed private convertible bonds for gross proceeds of KRW 1,000,000,000. The bonds have a maturity date of December 14, 2021, carry a coupon of 3% and yield to maturity of 7.5%. The bonds are convertible into 833,330 shares of the company at a fixed conversion price of KRW 1,200 per share. The conversion period will be from December 14, 2019 to December 13, 2021. The transaction has been approved by the board of directors of the company. The transaction will involve participation from Samwon Co.,Ltd and individual investors Jeonghwa Lee, Jeonghoon Im, Seri Im, Hyungju Yu, Chunghee Han, Kibong Lee, Injoo Yeo for KRW 100,000,000 each and individual investor Jiwon Ha for KRW 200,000,000.